In a landmark decision, the European Commission has approved GSK plc’s Omjjara (momelotinib), introducing a revolutionary treatment for adult myelofibrosis patients suffering from moderate to severe anaemia. This authorization positions Omjjara as the first medicine in the EU specifically targeting disease-related splenomegaly (enlarged spleen) or symptoms in this patient demographic, whether newly diagnosed or previously […]
GSK has secured the approval of the US Food and Drug Administration (FDA) for the company’s Jesduvroq (daprodustat) for anaemia of chronic kidney disease (CKD) in adults on dialysis. Jesduvroq is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor indicated for the daily once treatment of anaemia due to CKD in adults on dialysis for at […]
GlaxoSmithKline (GSK) has agreed to acquire Sierra Oncology, a California-based biopharma company, in a deal worth around $1.9 billion (£1.5 billion). As per the terms of the deal, shareholders of the publicly-listed Sierra Oncology will be paid $55 per share in cash. Sierra Oncology is engaged in developing targeted therapies for the treatment of rare […]
Anaemia is the condition of the blood characterized by decrease in the hemoglobin count due to deficiency of iron and also due to lack of Vitamin B12, B6, Copper of Folic acid. To know more about anaemia and its deficiency disease check What is meant by Anaemia? Deficiency diseases and foods to treat anaemia. Below […]
What is meant by Anaemia? Haemoglobin is the compound which carries oxygen to the body tissues from the lungs. Anaemia itself is not a disease and it is a symptom of some other disease such as deficiency of iron in the diet, excessive loss of blood due to injury or heavy menstrual flow, infection by […]
